Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881

European Urology

Volumn 55, Issue 1, 2009, Pages 28-34

  Blom, Jan H M ^a   van Poppel, Hein ^b   Maréchal, Jean M ^c   Jacqmin, Didier ^d   Schröder, Fritz H ^e   de Prijck, Linda ^f   Sylvester, Richard ^f  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HÔPITAL CIVIL   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f EORTC DATA CENTER   (Belgium)

Author keywords

Lymph node dissection; Lymph node metastases; Radical nephrectomy; Renal cell cancer; Survival

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EMBOLISM; EUROPE; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHRECTOMY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPHRECTOMY; PROSPECTIVE STUDIES;

EID: 56249090670     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.09.052     Document Type: Article

References (26)

1. Thrasher J.B., and Paulson D.F. Prognostic factors in renal cancer. Urol Clin N Am 20 (1993) 247-262
2. Campbell S.C., Novick A.C., and Bukowski R.M. Renal tumors. In: Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., and Peters C.A. (Eds). Campbell-Walsh Urology (2007), Saunders, Philadelphia, PA 1567-1637
3. Robson C.J., Churchill B.M., and Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 101 (1969) 297-301
4. Hultèn L., Rosencrantz M., Seeman T., Wahlqvist L., and Ahrén C. Occurence and localization of lymph node metastases in renal carcinoma. Scand J Urol Nephrol 3 (1969) 129-130
5. Angervall L., and Wahlqvist L. Follow-up and prognosis of renal carcinoma in a series operated by perifascial nephrectomy with adrenalectomy and retroperitoneal lymphadenectomy. Eur Urol 4 (1978) 13-17
6. Waters W.B., and Richie J.P. Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol 122 (1979) 306-309
7. Petkovic S. The value of tumor tissue penetration into the renal veins and lymph nodes as anatomical classification and kidney tumor prognostic parameters. Eur Urol 6 (1980) 289-292
8. Pizzocaro G., and Piva L. Pros and cons of retroperitoneal lymphadenectomy in operable renal cell carcinoma. Eur Urol 18 Suppl 2 (1990) 22-23
9. Giberti C., Oneto F., Martorana G., Rovida S., and Carmignani G. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol 31 (1997) 40-48
10. Herrlinger A., Schrott K.M., Sigel A., and Giedl J. Results of 381 transabdominal radical nephrectomies for renal cell carcinoma with partial and complete en bloc lymph-node dissection. World J Urol 2 (1984) 114-121
11. Giuliani L., Martorana G., Giberti C., Pescatore D., and Magnani G. Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 130 (1983) 664-668
12. Robson C.J. Radical nephrectomy for renal cell carcinoma. J Urol 89 (1963) 37-42
13. Blom J.H.M., van Poppel H., Marechal J.M., et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. Eur Urol 36 (1999) 570-575
14. McDonald M.W. Current therapy for renal cell carcinoma. J Urol 127 (1982) 211-217
15. Harmer MH, ed. TNM-classification of malignant tumours. Geneva, Switzerland: UICC, International Union Against Cancer; 1978.
16. Stein J.P., and Skinner D.G. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin N Am 32 (2005) 187-197
17. Kondo T., Nakazawa H., Ito F., Hashimoto Y., Toma H., and Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 178 (2007) 1212-1217
18. Joslyn S.A., and Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68 (2006) 121-125
19. Guiliani L., Giberti C., Martorana G., and Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 143 (1990) 468-477
20. Siminovitch J.P., Montie J.E., and Straffon R.A. Lymphadenectomy in renal adenocarcinoma. J Urol 127 (1982) 1090-1091
21. Joslyn S.A., Sirintrapun S.J., and Konety B.R. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the national surveillance, epidemiology, and end results database. Urology 65 (2005) 675-680
22. Pantuck A.J., Zisman A., Dorey F., et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 169 (2003) 2076-2083
23. Canfield S.E., Kamat A.M., Sánchez-Ortiz R.F., Detry M., Swanson D.A., and Wood C.G. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 175 (2006) 864-869
24. Minervini A., Lilas L., Morelli G., et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?. BJU Int 88 (2001) 169-172
25. Schafhauser W., Ebert A., Brod J., Petsch S., and Schrott K.M. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res 19 (1999) 1573-1578
26. Studer U.E., Scherz S., Scheidegger J., et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144 (1999) 243-245